MSF in Mumbai

After 18 years, MSF hands over its Drug-Resistant Tuberculosis (DR-TB) Project to the National TB Elimination Program in Mumbai

by

27 Sept 2024, Mumbai: Médecins Sans Frontières (MSF)/Doctors Without Borders today announced the planned closure of its Mumbai-based Drug-Resistant Tuberculosis (DR-TB) project by the end of 2024. This significant initiative has been providing comprehensive care to patients with complex cases of extensively drug-resistant TB (XDR-TB) since 2006. The project, which has played a pivotal role … Read more

India: Mumbai TB Symposium Focuses on Advancing TB Treatment and Collaboration

by

10 June 2024, Mumbai: A pivotal symposium organised today by Médecins Sans Frontières (MSF)/Doctors Without Borders brought together a diverse coalition of experts and stakeholders to forge actionable strategies against Drug-Resistant Tuberculosis (DRTB). This crucial gathering aimed to highlight the key successes and challenges in the battle against TB, with an emphasis on enhancing the … Read more

India: How Deepak Shegar overcame DR-TB to reclaim his dreams

by

Mumbai, India- “When I recover, I want to play cricket,” says Deepak Shegar, a 23-year-old whose aspirations extend far beyond his battle with drug-resistant tuberculosis (DR-TB). With dreams of a career in the garment industry, a love for cricket, and a desire for a brand-new bike, Deepak’s journey to pursue his goals has been long … Read more

Deepak Shegar: Battling DR-TB with resilience and dreams

by

“When I recover, I want to play cricket,” says Deepak Shegar, a 23-year-old whose aspirations extend far beyond his battle with drug-resistant tuberculosis (DR-TB). With dreams of a career in the garment industry, a love for cricket, and a desire for a brand-new bike, Deepak’s journey to pursue his goals has been long and challenging. … Read more

Namrata’s journey: triumph over drug-resistant Tuberculosis

by

Mumbai, India- Namrata’s story is a testament to the timeless principle that consistency is crucial. Her disciplined approach to maintaining a routine, embracing a healthy lifestyle, and adhering to medication regimens demonstrates that even formidable conditions like drug-resistant tuberculosis (DR-TB) can be overcome. In 2016, Namrata was employed at a daycare in an international school … Read more

Namrata’s Journey: Triumph Over Drug-Resistant Tuberculosis

by

Namrata’s story is a testament to the timeless principle that consistency is crucial. Her disciplined approach to maintaining a routine, embracing a healthy lifestyle, and adhering to medication regimens demonstrates that even conditions like drug-resistant tuberculosis (DR-TB) can be overcome. In 2016, Namrata was employed at a daycare in an international school in Chembur, Mumbai. … Read more

World Tuberculosis Day: Treating the untreatable

by

With 84,000 cases of drug-resistant tuberculosis, India has the highest burden of DR-TB in the world. In Mumbai, MSF has been providing not just medical treatment but holistic care to people living with DR-TB. Watch this video to find out more.

Renewed hope- Stories of four patients fighting drug-resistant-TB in Mumbai

by

Name : Designation : Interviews conducted & written by DVL Padma Priya for MSF   For World TB Day 2018, we celebrate the courage and endurance of four MSF patients who are currently undergoing treatment for drug-resistant TB (DR-TB).  Pooja, Rekha, Vikas and Sita are receiving care in MSF’s DR-TB programme in Mumbai, where a … Read more

Mumbai: A new life with new tuberculosis drugs

by

Increasingly drug-resistant strains of tuberculosis (TB) are on the rise in India, particularly in hotspots such as Mumbai. Two new TB drugs, bedaquiline and delaminid, show promising results and offer renewed hope to patients whose TB strains are resistant to nearly all drugs available. But access to these new life-saving drugs in India remains greatly … Read more

India: Renewed hope with new drugs

by

Two new drugs, bedaquiline and delamanid, are proving to be the very last lifeline for tuberculosis (TB) patients with the most extreme forms of drug resistance. While a few patients benefit from these new drugs in India, many die before being able to access them as they are not widely available. Nischaya, eighteen years old, receives the … Read more